Project Grant HT94252510027
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$614K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $623,003 Project Grant to Virginia Commonwealth University (VCU) under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from May 1, 2024 to April 30, 2027, will fund a longitudinal study to characterize the genetic architecture and risk factors for post-concussive symptoms, post-traumatic stress disorder, and alcohol use disorder in a military cohort. VCU has subawarded a portion of the grant to...
The federal Project Grant award of $860,998.00 was issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from April 1, 2025 to March 31, 2028, supports neurophysiology research focused on understanding the epileptogenesis signals and biomarkers underlying post-traumatic epilepsy. This research, conducted by the Regents of the University of California, San Francisco (UCSF), aims to...
The Defense Health Agency has awarded a $1.632 million Project Grant to the Ocean State Research Institute, Inc., a non-profit research organization, to investigate the long-term outcomes of antipsychotic medication use in U.S. veterans with post-traumatic stress disorder (PTSD). This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. As...
The federal Project Grant award, valued at $1,177,731.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by the Dartmouth-Hitchcock Clinic, a non-profit healthcare provider and academic medical center, to increase epilepsy self-management access for veterans through a "partnered hub and spoke model" approach. The project aims to transform healthcare for military service members and...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,047,751 Project Grant to the Portland VA Research Foundation, Inc. to conduct the "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE" research project. This 4-year award, beginning on Sep 1, 2024 and ending on Aug 31, 2028, will enable the Portland VA Research Foundation to carry out scientific research aimed at improving health outcomes for...
This federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is for a prospective randomized study of a novel EEG neurofeedback system for the treatment of PTSD using machine learning-based amygdala biomarkers. The total funding amount is $3,966,794.00, with a performance period from September 1, 2024 to August 31, 2027. The awardee, Foundation For Atlanta Veterans Education And Research, Inc., is a non-profit...
This federal Project Grant award of $5,954,349 from the Department of Defense's (DoD) Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial to optimize heart rate variability in combat veterans and service members with persistent post-concussion symptoms. The primary awardee, Virginia Commonwealth University (VCU), will conduct the clinical research trial in partnership with two sub-awardees - the Palo Alto Veterans Institute for Research...
This federal Project Grant award of $4,208,345.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) funds a HYBRID 1 EFFECTIVENESS-IMPLEMENTATION TRIAL OF PARTNER-ASSISTED PROLONGED EXPOSURE FOR PTSD. The grant was awarded on Sep 30, 2024 to the Regents of the University of Minnesota, a prominent land-grant research institution, with an ultimate completion date of Sep 29, 2028. The project aims to investigate innovative approaches to...
This $224,541 three-year Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports the VA Connecticut Research & Education Foundation, Inc. in increasing epilepsy self-management access for veterans. The foundation, a non-profit research organization located in West Haven, Connecticut, will embrace a "partnered hub and spoke" model to deliver this initiative over the April 1, 2025 to March 31, 2028...
This $839,745 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to improve care and outcomes for veterans with post-traumatic epilepsy. The grant was awarded to Baylor College of Medicine, a private health sciences university in Houston, Texas, to conduct research and develop new treatments in this area over the 3-year performance period from May 1, 2024 to April 30, 2027. As a leading academic medical center, Baylor...